Odyssey Therapeutics, Inc.
Biotechnology company · Boston, Massachusetts, United States · Nasdaq: ODTX
Odyssey Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker ODTX. It has reported private securities offerings to the US SEC, most recently $214 million sold in a notice filed in 2025.
Odyssey Therapeutics at a glance
What does Odyssey Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $214 million sold (2025).
Frequently asked questions about Odyssey Therapeutics
Where is Odyssey Therapeutics headquartered?
Odyssey Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Odyssey Therapeutics do?
Odyssey Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Odyssey Therapeutics a public company?
Yes. Odyssey Therapeutics, Inc. trades on Nasdaq under the ticker ODTX.
When was Odyssey Therapeutics founded?
The earliest incorporation on record for Odyssey Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.